Senores Pharmaceuticals Ltd (SENORES) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 10039497, "name": "Senores Pharma.", "stock_name": "Senores Pharma.", "full_name": "Senores Pharmaceuticals Ltd", "name_url": "stocks-analysis/senores-pharma", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "779.00", "chg": -5.25, "chgp": "-0.67%", "dir": -1, "prev_price": "784.25", "mcapval": "3,587.57 Cr", "mcap": "Small Cap", "scripcode": "544319", "symbol": "SENORES", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE0RB801010", "curr_date": "Apr 06", "curr_time": "", "bse_nse_vol": "2.62 lacs", "exc_status": "Active", "traded_date": "Apr 06, 2026", "traded_date_str": "2026 04 06", "score": "", "scoreText": "", "Live": 0, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/senores-pharma-10039497-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Senores Pharmaceuticals’ Mixed Week: -0.33% Price Change Amid Technical and Valuation Shifts", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-mixed-week--033-price-change-amid-technical-and-valuation-shifts-3931644", "imagepath": "", "date": "2026-04-04 09:03:15", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>30 Mar:</strong> Upgrade to Buy on strong financials and technical shift</p>\n <p><strong>30 Mar:</strong> Technical momentum shifts to mildly bullish</p>\n <p><strong>1 Apr:</strong> Significant gap up opens trading (+5.28%)</p>\n <p><strong>2 Apr:</strong> Downgrade to Hold amid mixed technicals and valuation concerns</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.788.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.785.40<..." }, { "title": "Senores Pharmaceuticals Downgraded to Hold Amid Mixed Technicals and Valuation Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/senores-pharmaceuticals-downgraded-to-hold-amid-mixed-technicals-and-valuation-concerns-3929729", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SenoresPharmace_mojoScore_3929729.png", "date": "2026-04-02 08:38:19", "description": "Senores Pharmaceuticals Ltd has seen its investment rating downgraded from Buy to Hold as of 1 April 2026, reflecting a nuanced reassessment across quality, valuation, financial trends, and technical indicators. Despite robust financial performance and market-beating returns, the company’s technical outlook and valuation metrics have prompted a more cautious stance from analysts." }, { "title": "Senores Pharmaceuticals Ltd Opens 5.28% Higher in Sharp Gap Up, But Can the Technicals Support It?", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-opens-strong-with-significant-gap-up-on-1-april-2026-3928183", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SenoresPharmace_gapup_3928183.png", "date": "2026-04-01 09:36:55", "description": "" }, { "title": "Senores Pharmaceuticals Upgraded to Buy on Strong Financials and Technical Shift", "link": "https://www.marketsmojo.com/news/stock-recommendation/senores-pharmaceuticals-upgraded-to-buy-on-strong-financials-and-technical-shift-3923548", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SenoresPharmace_mojoScore_3923548.png", "date": "2026-03-30 08:12:25", "description": "Senores Pharmaceuticals Ltd has been upgraded from a Hold to a Buy rating by MarketsMOJO as of 27 March 2026, reflecting significant improvements across quality, valuation, financial trends, and technical indicators. The company’s robust quarterly performance, market-beating returns, and evolving technical outlook have collectively driven this positive reassessment." }, { "title": "Senores Pharmaceuticals Ltd Shows Technical Momentum Shift Amid Positive Market Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-shows-technical-momentum-shift-amid-positive-market-returns-3923494", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SenoresPharmace_technicaldot_3923494.png", "date": "2026-03-30 08:03:24", "description": "Senores Pharmaceuticals Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, moving averages, and volume-based metrics, suggesting cautious optimism for investors in this small-cap pharmaceutical player." }, { "title": "Senores Pharmaceuticals Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/senores-pharmaceuticals-ltd-is-rated-buy-3922807", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SenoresPharmace_mojoScore_3922807.png", "date": "2026-03-29 10:10:14", "description": "Senores Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 27 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 March 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, returns, and overall outlook." }, { "title": "Senores Pharmaceuticals Gains 4.86%: 2 Key Factors Driving the Weekly Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-gains-486-2-key-factors-driving-the-weekly-momentum-3921210", "imagepath": "", "date": "2026-03-28 09:04:51", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>23 Mar:</strong> Sharp decline of 5.32% amid broad market sell-off</p>\n <p><strong>24 Mar:</strong> Recovery with 2.77% gain supported by positive market sentiment</p>\n <p><strong>25 Mar:</strong> Intraday high surge of 7.65%, closing at Rs.779.60 (+6.62%)</p>\n <p><strong>27 Mar:</strong> Mixed technical signals as stock gains 1.08% despite Sensex fall</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.751.45</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</di..." }, { "title": "Senores Pharmaceuticals Ltd Shows Mixed Technical Signals Amid Price Momentum Shift", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-shows-mixed-technical-signals-amid-price-momentum-shift-3918567", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SenoresPharmace_technicaldot_3918567.png", "date": "2026-03-27 08:03:26", "description": "Senores Pharmaceuticals Ltd has experienced a notable shift in price momentum, reflected in a 6.91% gain on 27 Mar 2026, moving the stock from a mildly bearish technical stance to a more sideways trend. This article analyses the latest technical indicators, including MACD, RSI, moving averages, and volume trends, to provide a comprehensive view of the stock’s current positioning within the Pharmaceuticals & Biotechnology sector." }, { "title": "Senores Pharmaceuticals Ltd Surges 7.65% to Day's High of Rs 787.15 — Outperforms Sector by 6 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-intraday-high-with-765-surge-on-25-mar-2026-3916003", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SenoresPharmace_priceRelatedfactors_3916003.png", "date": "2026-03-25 10:21:36", "description": "The Sensex climbed 1.67% on 25 Mar 2026, yet Senores Pharmaceuticals Ltd outpaced the broader market with a 7.65% gain, reaching an intraday high of Rs 787.15. This 6-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift." } ], "total": 191, "sid": "10039497", "stock_news_url": "https://www.marketsmojo.com/news/senores-pharmaceuticals-10039497" }, "announcements": "", "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

30 Mar: Upgrade to Buy on strong financials and technical shift

30 Mar: Technical momentum shifts to mildly bullish

1 Apr: Significant gap up opens trading (+5.28%)

2 Apr: Downgrade to Hold amid mixed technicals and valuation concerns

Read full news article

Senores Pharmaceuticals Downgraded to Hold Amid Mixed Technicals and Valuation Concerns

2026-04-02 08:38:19

Senores Pharmaceuticals Ltd has seen its investment rating downgraded from Buy to Hold as of 1 April 2026, reflecting a nuanced reassessment across quality, valuation, financial trends, and technical indicators. Despite robust financial performance and market-beating returns, the company’s technical outlook and valuation metrics have prompted a more cautious stance from analysts.

Read full news article

Senores Pharmaceuticals Ltd Opens 5.28% Higher in Sharp Gap Up, But Can the Technicals Support It?

2026-04-01 09:36:55

Read full news article

Senores Pharmaceuticals Upgraded to Buy on Strong Financials and Technical Shift

2026-03-30 08:12:25

Senores Pharmaceuticals Ltd has been upgraded from a Hold to a Buy rating by MarketsMOJO as of 27 March 2026, reflecting significant improvements across quality, valuation, financial trends, and technical indicators. The company’s robust quarterly performance, market-beating returns, and evolving technical outlook have collectively driven this positive reassessment.

Read full news article

Senores Pharmaceuticals Ltd Shows Technical Momentum Shift Amid Positive Market Returns

2026-03-30 08:03:24

Senores Pharmaceuticals Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, moving averages, and volume-based metrics, suggesting cautious optimism for investors in this small-cap pharmaceutical player.

Read full news article

Senores Pharmaceuticals Ltd is Rated Buy

2026-03-29 10:10:14

Senores Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 27 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 March 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, returns, and overall outlook.

Read full news article

Senores Pharmaceuticals Gains 4.86%: 2 Key Factors Driving the Weekly Momentum

2026-03-28 09:04:51

Key Events This Week

23 Mar: Sharp decline of 5.32% amid broad market sell-off

24 Mar: Recovery with 2.77% gain supported by positive market sentiment

25 Mar: Intraday high surge of 7.65%, closing at Rs.779.60 (+6.62%)

27 Mar: Mixed technical signals as stock gains 1.08% despite Sensex fall

Week Open

Rs.751.45

Week CloseRead full news article

Senores Pharmaceuticals Ltd Shows Mixed Technical Signals Amid Price Momentum Shift

2026-03-27 08:03:26

Senores Pharmaceuticals Ltd has experienced a notable shift in price momentum, reflected in a 6.91% gain on 27 Mar 2026, moving the stock from a mildly bearish technical stance to a more sideways trend. This article analyses the latest technical indicators, including MACD, RSI, moving averages, and volume trends, to provide a comprehensive view of the stock’s current positioning within the Pharmaceuticals & Biotechnology sector.

Read full news article

Senores Pharmaceuticals Ltd Surges 7.65% to Day's High of Rs 787.15 — Outperforms Sector by 6 Percentage Points

2026-03-25 10:21:36

The Sensex climbed 1.67% on 25 Mar 2026, yet Senores Pharmaceuticals Ltd outpaced the broader market with a 7.65% gain, reaching an intraday high of Rs 787.15. This 6-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift.

Read full news article

View All News